Browsing by Author "Ozcelik, Melike"
Now showing items 1-3 of 3
-
Comparison of the efficacy and safety of 3 months of CAPOX followed by 3 months of capecitabine and 6 months of CAPOX/FOLFOX in the adjuvant treatment of low-risk stage-III colon cancer treated surgically
Bardakci, Murat; Esmer, Derya; Hafizoglu, Emre; Yaslikaya, Sendag; Genc, Tugrul Burak; Ozcelik, Melike; Erdat, Efe Cem (Karger, 2023)Introduction: In the adjuvant treatment of low-risk stage-III colon cancer treated surgically, 3 months of CAPOX followed by 3 months of capecitabine is not a common clinical practice. Since there are no data on this ... -
Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study
Koca, Sinan; Besiroglu, Mehmet; Ozcelik, Melike; Karaca, Mustafa; Bilici, Mehmet; Hacioglu, Bekir; Dogu, Gamze G. (Sage Publications Ltd, 2021)Purpose Soft tissue sarcomas are associated with a poor prognosis and low chemotherapeutic efficiency. Pazopanib is an orally available multi-tyrosine kinase inhibitor that was explored in patients with non-adipocytic ... -
Retrospective evaluation of premenopausal hormone-sensitive breast cancer patients treated with adjuvant gonadotropin-releasing hormone analogue.
Demirci, Ayse; Alkis, Necati; Dane, Faysal; Yazilitas, Dogan; Durnali, Ayse; Inanc, Mevlude; Ozcelik, Melike (Lippincott Williams & Wilkins, 2014)[Abstract Not Available]
